Skip to main content
Log in

Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease?

  • Practice Point
  • Published:

From Nature Clinical Practice Rheumatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. American Thoracic Society and European Respiratory Society (2001) International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165: 277–304

  2. Douglas WW et al. (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164: 1182–1185

    Article  CAS  Google Scholar 

  3. King TE Jr et al. (2005) Analyses of efficacy end points in a controlled trial of interferon-γ1b for idiopathic pulmonary fibrosis. Chest 127: 171–177

    Article  CAS  Google Scholar 

  4. Nicholson AG et al. (2000) The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162: 2213–2217

    Article  CAS  Google Scholar 

  5. Ramos C et al. (2001) Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 24: 591–598

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tim Bongartz.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bongartz, T., Ryu, J. & Matteson, E. Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease?. Nat Rev Rheumatol 1, 80–81 (2005). https://doi.org/10.1038/ncprheum0067

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0067

  • Springer Nature Limited

Navigation